Table of Contents
Volume 7 | Supplement 3
Publication Date: November 2005- Abstract
- No Access
- Pay-Per View
- Full Text
- Add to Cart
Contributions | ||
S76 |
Current Therapeutic Strategies in Non–Small-Cell Lung Cancer: Evolving Role of Docetaxel Roy S. Herbst |
|
S77-S82 |
First-Line Chemotherapy for Advanced-Stage Non–Small-Cell Lung Cancer: Focus on Docetaxel Suresh Ramalingam |
|
S83-S86 |
Novel Combinations with Docetaxel in the Treatment of Non–Small-Cell Lung Cancer Edward S. Kim, Ewan D. Johnson |
|
S87-S92 |
The Role of Docetaxel in N2 Locally Advanced Non–Small-Cell Lung Cancer Giancarlo Pillot, Ramaswamy Govindan |
|
S93-S97 |
Therapeutic Strategies for Combined-Modality Therapy of Locally Advanced Non–Small-Cell Lung Cancer: Rationale for Consolidation Docetaxel Therapy David R. Gandara, Eric Vallières, Laurie E. Gaspar, Karen Kelly, Kathy S. Albain, Roy S. Herbst, Jr, Primo N. Lara, Jr, Philip Mack, Paul H. Gumerlock, John J. Crowley |
|
S98-S104 |
Adjuvant and Neoadjuvant Therapy for Early-Stage Non–Small-Cell Lung Cancer Nicholas W. Choong, Everett E. Vokes |
|